From Casetext: Smarter Legal Research

Commercial Union Ins. Co. v. Pfizer, Inc.

Appellate Division of the Supreme Court of New York, First Department
Feb 1, 1994
201 A.D.2d 273 (N.Y. App. Div. 1994)

Opinion

February 1, 1994

Appeal from the Supreme Court, New York County (Seymour Schwartz, J.).


The court did not abuse its discretion in denying plaintiff leave to add a class of insurance coverage claims, arising from different underlying substantive claims from those originally asserted herein, where the proposed new claims have already been brought before the courts of the State of New Jersey, only a small minority of the contaminated sites are located in New York, and no other significant nexus between New York and these claims has been demonstrated. The negotiation and execution of the insurance contracts in New York does not necessarily make New York the only appropriate forum for disputes concerning their coverage (Avnet, Inc. v. Aetna Cas. Sur. Co., 160 A.D.2d 463, 464). Nor has plaintiff shown a sufficient nexus between the extant New York claims, concerning coverage for personal injuries arising out of exposure to, or ingestion of, toxic substances, and the site-contamination claims being litigated in New Jersey, such as to persuade us that judicial economy and a concern for uniform results would warrant the grant of leave to amend so as to effect joinder of the actions.

Concur — Sullivan, J.P., Ellerin, Kupferman, Rubin and Tom, JJ.


Summaries of

Commercial Union Ins. Co. v. Pfizer, Inc.

Appellate Division of the Supreme Court of New York, First Department
Feb 1, 1994
201 A.D.2d 273 (N.Y. App. Div. 1994)
Case details for

Commercial Union Ins. Co. v. Pfizer, Inc.

Case Details

Full title:COMMERCIAL UNION INSURANCE COMPANY, Appellant, v. PFIZER, INC., et al.…

Court:Appellate Division of the Supreme Court of New York, First Department

Date published: Feb 1, 1994

Citations

201 A.D.2d 273 (N.Y. App. Div. 1994)
607 N.Y.S.2d 255

Citing Cases

Utica Mut. Ins. v. Bristol-Myers Squibb Co.

Neither Bristol-Myers nor defendant insurers chose New York as the forum. Rather, Bristol-Myers has…